182 related articles for article (PubMed ID: 24506807)
1. Effects of a domain-selective ACE inhibitor in a mouse model of chronic angiotensin II-dependent hypertension.
Burger D; Reudelhuber TL; Mahajan A; Chibale K; Sturrock ED; Touyz RM
Clin Sci (Lond); 2014 Jul; 127(1):57-63. PubMed ID: 24506807
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetic evaluation of lisinopril-tryptophan, a novel C-domain ACE inhibitor.
Denti P; Sharp SK; Kröger WL; Schwager SL; Mahajan A; Njoroge M; Gibhard L; Smit I; Chibale K; Wiesner L; Sturrock ED; Davies NH
Eur J Pharm Sci; 2014 Jun; 56():113-9. PubMed ID: 24561703
[TBL] [Abstract][Full Text] [Related]
3. Pharmacodynamic effects of C-domain-specific ACE inhibitors on the renin-angiotensin system in myocardial infarcted rats.
Sharp S; Poglitsch M; Zilla P; Davies NH; Sturrock ED
J Renin Angiotensin Aldosterone Syst; 2015 Dec; 16(4):1149-58. PubMed ID: 25757657
[TBL] [Abstract][Full Text] [Related]
4. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
Weir MR
Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185
[TBL] [Abstract][Full Text] [Related]
5. Effects of neutral endopeptidase inhibition and combined angiotensin converting enzyme and neutral endopeptidase inhibition on angiotensin and bradykinin peptides in rats.
Campbell DJ; Anastasopoulos F; Duncan AM; James GM; Kladis A; Briscoe TA
J Pharmacol Exp Ther; 1998 Nov; 287(2):567-77. PubMed ID: 9808682
[TBL] [Abstract][Full Text] [Related]
6. Interaction between neutral endopeptidase and angiotensin converting enzyme inhibition in rats with myocardial infarction: effects on cardiac hypertrophy and angiotensin and bradykinin peptide levels.
Duncan AM; James GM; Anastasopoulos F; Kladis A; Briscoe TA; Campbell DJ
J Pharmacol Exp Ther; 1999 Apr; 289(1):295-303. PubMed ID: 10087017
[TBL] [Abstract][Full Text] [Related]
7. Discordant responses to two classes of drugs acting on the renin-angiotensin system.
Sever PS; Chang CL
J Renin Angiotensin Aldosterone Syst; 2001 Mar; 2(1):25-30. PubMed ID: 11881062
[TBL] [Abstract][Full Text] [Related]
8. Similar renoprotection after renin-angiotensin-dependent and -independent antihypertensive therapy in 5/6-nephrectomized Ren-2 transgenic rats: are there blood pressure-independent effects?
Kujal P; Chábová VČ; Vernerová Z; Walkowska A; Kompanowska-Jezierska E; Sadowski J; Vaňourková Z; Husková Z; Opočenský M; Skaroupková P; Schejbalová S; Kramer HJ; Rakušan D; Malý J; Netuka I; Vaněčková I; Kopkan L; Cervenka L
Clin Exp Pharmacol Physiol; 2010 Dec; 37(12):1159-69. PubMed ID: 20880190
[TBL] [Abstract][Full Text] [Related]
9. Comparative antihypertensive and renoprotective effects of telmisartan and lisinopril after long-term treatment in hypertensive diabetic rats.
Wienen W; Richard S; Champeroux P; Audeval-Gerard C
J Renin Angiotensin Aldosterone Syst; 2001 Mar; 2(1):31-6. PubMed ID: 11881063
[TBL] [Abstract][Full Text] [Related]
10. Angiotensin II-dependent chronic hypertension and cardiac hypertrophy are unaffected by gp91phox-containing NADPH oxidase.
Touyz RM; Mercure C; He Y; Javeshghani D; Yao G; Callera GE; Yogi A; Lochard N; Reudelhuber TL
Hypertension; 2005 Apr; 45(4):530-7. PubMed ID: 15753233
[TBL] [Abstract][Full Text] [Related]
11. Pulse pressure lowering effect of dual blockade with candesartan and lisinopril vs. high-dose ACE inhibition in hypertensive type 2 diabetic subjects: a CALM II study post-hoc analysis.
Knudsen ST; Andersen NH; Poulsen SH; Eiskjaer H; Hansen KW; Helleberg K; Poulsen PL; Mogensen CE
Am J Hypertens; 2008 Feb; 21(2):172-6. PubMed ID: 18188164
[TBL] [Abstract][Full Text] [Related]
12. Effect of reduced angiotensin-converting enzyme gene expression and angiotensin-converting enzyme inhibition on angiotensin and bradykinin peptide levels in mice.
Campbell DJ; Alexiou T; Xiao HD; Fuchs S; McKinley MJ; Corvol P; Bernstein KE
Hypertension; 2004 Apr; 43(4):854-9. PubMed ID: 14769811
[TBL] [Abstract][Full Text] [Related]
13. Combined inhibition of neutral endopeptidase and angiotensin-converting enzyme by sampatrilat in essential hypertension.
Wallis EJ; Ramsay LE; Hettiarachchi J
Clin Pharmacol Ther; 1998 Oct; 64(4):439-49. PubMed ID: 9797801
[TBL] [Abstract][Full Text] [Related]
14. A vaccine for hypertension based on virus-like particles: preclinical efficacy and phase I safety and immunogenicity.
Ambühl PM; Tissot AC; Fulurija A; Maurer P; Nussberger J; Sabat R; Nief V; Schellekens C; Sladko K; Roubicek K; Pfister T; Rettenbacher M; Volk HD; Wagner F; Müller P; Jennings GT; Bachmann MF
J Hypertens; 2007 Jan; 25(1):63-72. PubMed ID: 17143175
[TBL] [Abstract][Full Text] [Related]
15. Clinical effects produced by a standardized herbal medicinal product of Hibiscus sabdariffa on patients with hypertension. A randomized, double-blind, lisinopril-controlled clinical trial.
Herrera-Arellano A; Miranda-Sánchez J; Avila-Castro P; Herrera-Alvarez S; Jiménez-Ferrer JE; Zamilpa A; Román-Ramos R; Ponce-Monter H; Tortoriello J
Planta Med; 2007 Jan; 73(1):6-12. PubMed ID: 17315307
[TBL] [Abstract][Full Text] [Related]
16. Cardioprotective effects of granulocyte colony-stimulating factor in angiotensin II-induced cardiac remodelling.
Jia N; Dong P; Huang Q; Jin W; Zhang J; Dai Q; Liu S
Clin Exp Pharmacol Physiol; 2009 Mar; 36(3):262-6. PubMed ID: 18785976
[TBL] [Abstract][Full Text] [Related]
17. Modulation of the renin-angiotensin-aldosterone system and cough.
Lacourcière Y; Lefebvre J
Can J Cardiol; 1995 Aug; 11 Suppl F():33F-39F. PubMed ID: 7664216
[TBL] [Abstract][Full Text] [Related]
18. Shifting trends in the pharmacologic treatment of hypertension in a Nigerian tertiary hospital: a real-world evaluation of the efficacy, safety, rationality and pharmaco-economics of old and newer antihypertensive drugs.
Adigun AQ; Ishola DA; Akintomide AO; Ajayi AA
J Hum Hypertens; 2003 Apr; 17(4):277-85. PubMed ID: 12714973
[TBL] [Abstract][Full Text] [Related]
19. Roles of the two active sites of somatic angiotensin-converting enzyme in the cleavage of angiotensin I and bradykinin: insights from selective inhibitors.
Georgiadis D; Beau F; Czarny B; Cotton J; Yiotakis A; Dive V
Circ Res; 2003 Jul; 93(2):148-54. PubMed ID: 12805239
[TBL] [Abstract][Full Text] [Related]
20. Blood pressure and renin-angiotensin system resetting in transgenic rats with elevated plasma Val5-angiotensinogen.
Bohlender J; Bader M; Ménard J; Nussberger J
J Hypertens; 2012 Aug; 30(8):1597-605. PubMed ID: 22728903
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
